- Grifols has been a trusted global provider of hepatitis B immune globulin (HBIG) for over 45 years and continues to expand its leadership in disease treatment with immunoglobulin (IgG), building out ...
Credit: Getty Images. HyperHEP B is the Grifol's new formulation of its hepatitis B immune globulin. Grifols announced the US launch of HyperHEP B ® for hepatitis B postexposure prophylaxis. HyperHEP ...
BARCELONA, Spain , June 1, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of a variety of postexposure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results